Page 1

HERANTIS PHARMA HER - 096 : Advancing Toward the First Disease - Modifying Treatment for Parkinson's Disease 1H 2026 Webcast August 2026 Herantis Pharma Oyj ( HEL : HRTIS ) Antti Vuolanto , D.Sc. CEO Tone Kvåle CFO Juha Savola , MD , PhD CMO antti.vuolanto@herantis.com 1